Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-22

Clinical Trial Update: Combination Oral Acetazolamide and Intravenous Furosemide on Acute Decompensated Heart Failure Outcomes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the combination of oral acetazolamide with intravenous furosemide for outcomes in acute decompensated heart failure; currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)
  • FUROSEMIDE (Furosemide)

Snippet

Sponsor: Universitas Diponegoro | Conditions: Acute Decompensated Heart Failure | Phase 4 | Status: RECRUITING